Name (Synonyms) | Correlation |
---|
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Facing the unusual situation imposed by the coronavirus disease, the aim of this study is to evaluate the risk and effects of less frequent hemodialysis on prevalent patients
Description: Time to all-cause and cardiovascular death
Measure: Mortality Time: From date of beginning of the study until the date of death assessed up to 52 weeksDescription: Time variation of the biological parameters mentioned in the title. Repeated measurements of laboratory variables will be averaged into patient quarterly means to minimize measurement variability.
Measure: Anemia, Nutrition, Adequation of dialysis, total ultrafiltration, ultrafiltration rate, Time: From date of beginning of the study assessed up to 52 weeksDescription: Time to first hospitalization of any cause
Measure: Hospitalization Time: From date of beginning of the study until the date of first hospitalization assessed up to 52 weeksDescription: Time to first endovascular or quirurgical intervention of the vascular access utilized at the start of the study
Measure: Vascular Access Time: From date of beginning of the study until the date of first intervention assessed up to 52 weeks